Corporate Banner
Satellite Banner
Technology Networks Header
Friday, July 25, 2014
 
Register | Sign in
Home Page>Products
  Product News
New Phenomenex GC Column Set for Chlorinated Pesticides
Friday, July 25, 2014
The Zebron ZB-CLPesticides GC column runs seven EPA methods.

MDxI Launches LabFile Data Resource
Friday, July 25, 2014
New standard for defining and targeting US clinical laboratory universe.

Cancer Conference Poster Prize Winner
Friday, July 25, 2014
Katarzyna Grzes announced as the winner of the AMSBIO-Trevigen prize for the best poster.

Reliable Assays for Sugars in Acid-Hydrolyzed Wood
Friday, July 25, 2014
Determination of common sugars by high-performance anion-exchange chromatography with pulsed amperometric detection methods.

EasyFinder Online Selection Tool from Mettler Toledo
Friday, July 25, 2014
New tool helps customers find the perfect laboratory balances and scales with just a few clicks of their mouse.

New Paraffin Section Flotation Bath from Electrothermal
Thursday, July 24, 2014
New bath updates Electrothermal’s extensive histology range.

EKF Diagnostics’ Growing Product Portfolio Highlighted at AACC 2014
Thursday, July 24, 2014
From early detection of ketosis to cancer mutation testing in whole blood.

Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology
Thursday, July 24, 2014
MuDT™ technology doubles the channel availability of any real-time PCR instrument.

R&D 100 Award 2014 for ZEISS ELYRA P.1 with 3D-PALM
Thursday, July 24, 2014
ZEISS is receiving Research & Development award once more.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 10358
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv